New research suggests the targeted radiation treatment may reduce long-term side effects while maintaining strong cancer ...

Ten years after his successful treatment at the Fred Hutch proton facility, patient Keith Abbott wrote a thank you note to the staff. Due to a family history of esophageal cancer, Abbott underwent ...

A contingent of Fred Hutch Cancer Center – Proton Therapy staff attended the National Association of Proton Therapy (NAPT) Conference in Boston last month. The conference, which hosted 335 members ...

The therapy is a highly advanced form of radiation therapy that uses charged particles in the form of a proton that that gets delivered with precision into a tumor that might be near a critical organ, ...

Leo Cancer Care's high-tech chair, which combines an upright patient positioning system and a CT scanner, received FDA clearance in July. Startup Leo Cancer Care is transforming proton radiation ...

Penn Medicine will open a fourth proton therapy center, expanding its ability to provide patients with the non-invasive cancer treatment that is associated with fewer side effects than other cancer ...

Please provide your email address to receive an email when new articles are posted on . Risk for late feeding tube dependence was low and did not differ between intensity-modulated radiation therapy ...

Proton Therapy reduces the risk of a second cancer diagnosis by 69% versus other forms of radiation treatment according to a paper recently released by a team from Stanford University. The study ...

After completing two courses of chemotherapy and a stem cell transplant for Hodgkin lymphoma, 15-year-old Ava Schmid became ...

Please provide your email address to receive an email when new articles are posted on . Men with low- or intermediate-risk prostate cancer achieved similar quality-of-life outcomes whether they ...

The Total Body MRI at Ackerman Cancer Center. Read full article: Understanding breast cancer screenings: When to start, symptoms to watch for, and the role of advanced mammography Dr. Scot Ackerman.